BAKER BIOTECH CAPITAL II GP LLC Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BIOTECH CAPITAL II GP LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BIOTECH CAPITAL II GP LLC. BAKER BIOTECH CAPITAL II GP LLC is 10% Owner in NEUROGEN CORP ($NRGN) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN).
BAKER BIOTECH CAPITAL II GP LLC in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BIOTECH CAPITAL II GP LLC: Director
Holdings: 264,773 shares
Current Value: $16,095,551
Latest Transaction: Apr 01 2005
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BIOTECH CAPITAL II GP LLC in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, NRGN, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 4.96 | 10,816 | 53,674 | 264,773 | 254 K to 264.8 K (+4.26 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 4.90 | 5,934 | 29,072 | 253,957 | 248 K to 254 K (+2.39 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 4.81 | 2,486 | 11,967 | 248,023 | 245.5 K to 248 K (+1.01 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 4.90 | 809 | 3,964 | 245,537 | 244.7 K to 245.5 K (+0.33 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 4.96 | 71,227 | 353,250 | 244,728 | 173.5 K to 244.7 K (+41.05 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 4.99 | 51 | 254 | 173,501 | 173.5 K to 173.5 K (+0.03 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.04 | 74,167 | 373,557 | 173,450 | 99.3 K to 173.5 K (+74.70 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 4.88 | 5,234 | 25,537 | 99,283 | 94 K to 99.3 K (+5.57 %) |
| Nov 03 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Option Exercise | J | 2.50 | 34,385 | 85,963 | 249,730 | |
| Nov 03 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Option Exercise | J | 6.25 | 42,981 | 268,631 | 312,162 | |
| Nov 03 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Sell | J | 0.00 | 13,542 | 0 | 94,049 | 107.6 K to 94 K (-12.59 %) |
| Aug 12 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.58 | 28,031 | 156,365 | 108,427 | 80.4 K to 108.4 K (+34.87 %) |
| Aug 12 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.42 | 4,481 | 24,283 | 80,396 | 75.9 K to 80.4 K (+5.90 %) |
| Aug 12 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.49 | 935 | 5,133 | 75,915 | 75 K to 75.9 K (+1.25 %) |
| Aug 12 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.32 | 12,298 | 65,400 | 74,980 | 62.7 K to 75 K (+19.62 %) |
| Aug 09 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.50 | 4,409 | 24,250 | 62,682 | 58.3 K to 62.7 K (+7.57 %) |
| Aug 09 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.54 | 17,480 | 96,860 | 58,273 | 40.8 K to 58.3 K (+42.85 %) |
| Aug 04 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.58 | 16,557 | 92,368 | 40,793 | 24.2 K to 40.8 K (+68.32 %) |
| Aug 04 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.71 | 13,665 | 78,057 | 24,236 | 10.6 K to 24.2 K (+129.27 %) |
| Aug 04 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.98 | 9,402 | 56,220 | 10,571 | 1.2 K to 10.6 K (+804.28 %) |
| Aug 04 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 5.89 | 1,169 | 6,885 | 1,169 | 0 to 1.2 K |
Page: 1